Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Minerva Neurosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q4 2022
- Shares held
- 1.68M
- −48.7K (−2.8%) vs. Q4 2022
- Total value
- $2.69M
- −$61.2K (−2.2%) vs. Q4 2022
- New holders
- 2
- 2 more added
- Sold out
- 4
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,201,275 | $1.92M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 193,938 | $310.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 110,800 | $177.0K | 0.00% | +500+0.5% | Added |
| BlackRock Inc. | 78,831 | $126.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 41,064 | $65.7K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 28,341 | $44.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 13,719 | $21.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,575 | $13.7K | 0.00% | −100−1.2% | Reduced |
| Wells Fargo & Company | 1,975 | $3.16K | 0.00% | +1+0.1% | Added |
| Russell Investments Group, Ltd. | 1,175 | $1.88K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 822 | $1.00K | 0.00% | +822 | New |
| TFC Financial Management | 186 | $298 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 100 | $160 | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 100 | $160 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 12 | $19 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 176 | $0 | 0.00% | +176 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,881−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −15,436−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,785−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |